A comparison of treatment outcomes by radiochemotherapy and postoperative radiotherapy in locally advanced squamous cell carcinomas of head and neck.

@article{Fortin2008ACO,
  title={A comparison of treatment outcomes by radiochemotherapy and postoperative radiotherapy in locally advanced squamous cell carcinomas of head and neck.},
  author={A Bonneau Fortin and Richard Caouette and Chang Shu Wang and {\'E}ric Vigneault},
  journal={American journal of clinical oncology},
  year={2008},
  volume={31 4},
  pages={
          379-83
        }
}
PURPOSE To investigate the treatment outcomes by concomitant radiochemotherapy (CHEMORAD), and by surgery and postoperative radiotherapy (PORT) in patients with locally advanced head and neck cancers. METHOD A retrospective study included all patients with Stage III and IV (except T1-2 N1) diseases between 1989 and 2002 treated with CHEMORAD (163 patients) or PORT (424 patients) at the L'Hôtel-Dieu de Québec. Chemotherapy was realized with Cisplatin (DDP) 100 mg/m(2), d1, d23, and d45 during… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 15 REFERENCES

Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer.

  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2000
VIEW 2 EXCERPTS

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.

  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 1998
VIEW 1 EXCERPT